BRIEF published on 03/17/2026 at 07:35, 8 days 12 hours ago TRACTIAL submits a PSCA application to strengthen its stablecoin offering Stablecoins Financial Infrastructure TRACTIAL Embedded Finance MiCA
BRIEF published on 03/17/2026 at 07:35, 8 days 12 hours ago Tractial Files demande à MiCA de renforcer son offre de stablecoins Blockchain Stablecoins Règlement MiCA Finance Intégrée Paiements En Euros
BRIEF published on 03/17/2026 at 07:35, 8 days 12 hours ago Oeneo launches a €21 million share buyback program Share Buyback Treasury Oeneo Caspar SAS Accelerating Effect
BRIEF published on 03/17/2026 at 07:10, 8 days 13 hours ago Sequential Secures $3.5M for AI-Driven Skin Health Platform AI-powered Platform Funding Round Biomarker Discovery Sequential Skin Health Innovation
BRIEF published on 03/17/2026 at 07:10, 8 days 13 hours ago Sequential lève 3,5 millions de dollars pour sa plateforme de santé cutanée basée sur l'IA Plateforme Alimentée Par L'IA Découverte De Biomarqueurs Tour De Financement Séquentiel Innovation En Matière De Santé De La Peau
BRIEF published on 03/17/2026 at 07:08, 8 days 13 hours ago Sartorius Stedim Biotech Sets New Growth Targets with Biopharma Focus Advanced Therapies Market Expansion Growth Targets Biopharma Strategy Bioprocessing Technologies
BRIEF published on 03/17/2026 at 07:08, 8 days 13 hours ago Sartorius Stedim Biotech se fixe de nouveaux objectifs de croissance axés sur le secteur biopharmaceutique. Objectifs De Croissance Thérapies Avancées Expansion Du Marché Stratégie Biopharmaceutique Technologies De Bioprocédés
BRIEF published on 03/17/2026 at 07:08, 8 days 13 hours ago Sartorius Stedim Biotech affine sa stratégie et vise une croissance ambitieuse EBITDA Sartorius Stedim Biotech Objectifs De Croissance Stratégie Biopharmaceutique Portefeuille Produits
BRIEF published on 03/17/2026 at 07:08, 8 days 13 hours ago Sartorius Stedim Biotech refines its strategy and aims for ambitious growth EBITDA Sartorius Stedim Biotech Product Portfolio Growth Objectives Biopharmaceutical Strategy
BRIEF published on 03/17/2026 at 07:05, 8 days 13 hours ago PolyPeptide Announces 2026 Annual General Meeting Annual General Meeting Financial Statements Board Re-election PolyPeptide Group Compensation Approval
Published on 03/25/2026 at 19:15, 1 hour 18 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 7 hours 3 minutes ago Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 7 hours 3 minutes ago Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/25/2026 at 13:25, 7 hours 8 minutes ago Predictiv AI Expands Active Deployment of CloudRep.ai Across Healthcare, Retail, Real Estate, Travel and Global Markets
Published on 03/25/2026 at 20:00, 33 minutes ago Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 19:41, 52 minutes ago EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026
Published on 03/25/2026 at 19:30, 1 hour 3 minutes ago AIXTRON to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 19:26, 1 hour 7 minutes ago EQS-Adhoc: AIXTRON SE to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 18:40, 1 hour 53 minutes ago TULKUBASH AND KYZYLTASH MINING ASSETS: DECLARATION FROM A GROUP OF INVESTORS
Published on 03/25/2026 at 18:53, 1 hour 39 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:31, 2 hours 2 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 18:31, 2 hours 2 minutes ago Performance soutenue des Investissements et déploiement actif de la stratégie
